Overview
Pediatrics Regulatory Landscape
The regulatory environment for pediatrics therapies involves specialized requirements from FDA Office of Pediatric Therapeutics, EMA Paediatric Committee (PDCO), PMDA Pediatric Drug Review. This guide maps each requirement to ArcaScience's platform capabilities, demonstrating how AI-driven benefit-risk analysis aligns with and accelerates regulatory compliance.
Regulatory Requirements
Key Requirements by Agency
FDA Requirements
- ✓ Pediatric Research Equity Act (PREA) requirements
- ✓ Best Pharmaceuticals for Children Act (BPCA)
- ✓ Pediatric study plan (PSP) submission requirements
- ✓ Pediatric formulation guidance
- ✓ Pediatric post-marketing safety requirements
EMA Requirements
- ✓ Paediatric Investigation Plan (PIP) requirements
- ✓ Age-appropriate formulation guidance
- ✓ Paediatric Committee (PDCO) procedures
- ✓ Pediatric extrapolation framework
- ✓ Paediatric-specific PSUR requirements
PMDA Requirements
- ✓ Japan pediatric drug development requirements
- ✓ Pediatric clinical trial guidance
- ✓ Post-marketing pediatric safety monitoring
- ✓ Pediatric formulation requirements
ArcaScience Alignment
How ArcaScience Maps to Pediatrics Requirements
Data Coverage
Pediatrics-specific data from 47+ global sources, pre-harmonized and validated for regulatory submissions.
AI Models
Pediatrics-trained AI models for adverse event classification, signal detection, and benefit quantification with regulatory validation.
Regulatory Outputs
Pre-formatted outputs aligned with FDA Office of Pediatric Therapeutics and EMA Paediatric Committee (PDCO) submission requirements.
Download
Get the Full Pediatrics Regulatory Landscape
Complete the form below to receive the document via email.
Related Resources